<SEC-DOCUMENT>0001140361-25-021125.txt : 20250602
<SEC-HEADER>0001140361-25-021125.hdr.sgml : 20250602
<ACCEPTANCE-DATETIME>20250602162509
ACCESSION NUMBER:		0001140361-25-021125
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20250602
DATE AS OF CHANGE:		20250602
EFFECTIVENESS DATE:		20250602

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NU SKIN ENTERPRISES, INC.
		CENTRAL INDEX KEY:			0001021561
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				870565309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-287723
		FILM NUMBER:		251015323

	BUSINESS ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: GREGORY BELLISTON
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601
		BUSINESS PHONE:		801-345-1000

	MAIL ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: GREGORY BELLISTON
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ENTERPRISES INC
		DATE OF NAME CHANGE:	19980909

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ASIA PACIFIC INC
		DATE OF NAME CHANGE:	19960919
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>ef20049856_s8.htm
<DESCRIPTION>FORM S-8
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; font-weight: bold;"><a name="Section1"></a>As filed with the Securities and Exchange Commission on June 2, 2025.</div>
    <div>&#160;</div>
    <div style="text-align: right; font-weight: bold;">Registration No. 333-______</div>
    <div>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: center; font-weight: bold; font-size: 14pt;">UNITED STATES</div>
    <font style="font-size: 14pt;"> </font>
    <div style="text-align: center; font-weight: bold; font-size: 14pt;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; font-weight: bold; font-size: 12pt;">Washington, D.C. 20549</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: center;">
      <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; font-weight: bold; font-size: 18pt;">FORM S-8</div>
    <div style="text-align: center; font-weight: bold;">REGISTRATION STATEMENT</div>
    <div style="text-align: center; font-style: italic; font-weight: bold;">UNDER</div>
    <div style="text-align: center; font-style: italic; font-weight: bold;">THE SECURITIES ACT OF 1933</div>
    <div>&#160;
      <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; font-weight: bold; font-size: 24pt;">NU SKIN ENTERPRISES, INC.</div>
    <div style="text-align: center;">(Exact name of registrant as specified in its charter)</div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div> <br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z1dccb1dce1a247579904578812529497">

        <tr>
          <td style="width: 49.44%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Delaware</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">&#160;</td>
          <td style="width: 49.44%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">87-0565309</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49.44%; vertical-align: top;">
            <div style="text-align: center; color: #000000;">(State or other jurisdiction of incorporation or organization)</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">&#160;</td>
          <td style="width: 49.44%; vertical-align: top;">
            <div style="text-align: center; color: #000000;">(I.R.S. Employer Identification No.)</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">75 West Center Street</div>
    <div style="text-align: center; font-weight: bold;">Provo, Utah 84601</div>
    <div style="text-align: center;">(Address of Principal Executive Offices) (Zip Code)</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">Nu Skin Enterprises, Inc. Amended and Restated 2024 Omnibus Incentive Plan</div>
    <div style="text-align: center;">(Full title of the plan)</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;">Chayce D. Clark</div>
    <div style="text-align: center; font-weight: bold;">Executive Vice President and General Counsel</div>
    <div style="text-align: center; font-weight: bold;">Nu Skin Enterprises, Inc.</div>
    <div style="text-align: center; font-weight: bold;">75 West Center Street</div>
    <div style="text-align: center; font-weight: bold;">Provo, Utah 84601</div>
    <div style="text-align: center; font-weight: bold;">&#160;(801) 345-1000</div>
    <div style="text-align: center;">(Name, address and telephone number, including area code, of agent for service)</div>
    <div>&#160;
      <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; font-style: italic; font-weight: bold;">With copies to:</div>
    <div style="text-align: center; font-weight: bold;">Jay H. Knight</div>
    <div style="text-align: center; font-weight: bold;">Barnes &amp; Thornburg LLP</div>
    <div style="text-align: center; font-weight: bold;">1600 West End Avenue, Suite 800</div>
    <div style="text-align: center; font-weight: bold;">Nashville, TN 37203-3494</div>
    <div style="text-align: center; font-weight: bold;">(615) 621-6100</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; width: 20%; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div>&#160;</div>
    <div>Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated
      filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" style="border-collapse: collapse; width: 80%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" id="zf368cf5ef3944de1a47d156594fe6db0">

        <tr>
          <td style="width: 24%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Large accelerated filer</div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#9744;</td>
          <td style="width: 18.18%; vertical-align: bottom;">&#160;</td>
          <td style="width: 30%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Accelerated filer</div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#9745;</td>
        </tr>
        <tr>
          <td style="width: 24%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Non-accelerated filer</div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#9744;</td>
          <td style="width: 18.18%; vertical-align: bottom;">&#160;</td>
          <td style="width: 30%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Smaller reporting company</div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#9744;</td>
        </tr>
        <tr>
          <td style="width: 24%; vertical-align: bottom;">&#160;</td>
          <td style="width: 4%; vertical-align: bottom;">&#160;</td>
          <td style="width: 18.18%; vertical-align: bottom;">&#160;</td>
          <td style="width: 30%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Emerging growth company</div>
          </td>
          <td style="width: 4%; vertical-align: bottom;">&#9744;</td>
        </tr>

    </table>
    <div>&#160;</div>
    <div>If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the
      Securities Act.&#160; &#9744;</div>
    <div>&#160;</div>
    <div>
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;"><a name="Section2"></a>EXPLANATORY NOTE</div>
    <div>&#160;</div>
    <div style="text-align: justify;">This Registration Statement on Form S-8 is being filed by Nu Skin Enterprises, Inc. (the &#8220;Company&#8221;), a Delaware corporation, for the purpose of registering 790,000 additional shares of Company Class A common stock, par
      value $0.001 (the &#8220;Common Stock&#8221;), for issuance under the Company&#8217;s Amended and Restated 2024 Omnibus Incentive Plan (the &#8220;Amended Plan&#8221;).&#160; On March 31, 2025, the Company&#8217;s Board of Directors approved the Amended Plan, which amends and restates the
      2024 Omnibus Incentive Plan effective as of June 5, 2024 (the &#8220;Plan&#8221;) in its entirety.&#160; The Amended Plan was later approved by the Company&#8217;s stockholders at the 2025 Annual Meeting of Stockholders.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">The 790,000 additional shares of Common Stock available for issuance under the Amended Plan registered pursuant to this Registration Statement are the same class as those registered on the <a href="https://www.sec.gov/Archives/edgar/data/1021561/000114036124029279/0001140361-24-029279-index.htm">Registration Statement on Form S-8</a> on June 7, 2024 (File No.&#160;333-280044) (the &#8220;Prior Registration Statement&#8221;), which is currently
      effective. Pursuant to General Instruction E to Form S-8, the contents of the Prior Registration Statement, including any amendments thereto or filings incorporated therein, are incorporated herein by reference, except as modified, supplemented or
      superseded herein.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-weight: bold;"><a name="Section3"></a>PART II</div>
    <div style="text-align: center; font-weight: bold;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>
    <div>&#160;</div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z43f1afcf177d46a28ca1fae5e572675c" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: left;"><font style="font-weight: bold;">Item 3.</font> <br>
              </div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div><font style="font-weight: bold;">Incorporation of Documents by Reference.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div style="text-align: justify;">The following documents, which have been filed with the Securities and Exchange Commission (the &#8220;Commission&#8221;) by the Company, are incorporated by reference in this Registration Statement, except to the extent that
      information therein is deemed furnished and not filed pursuant to securities laws and regulations:</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z709292807540436ebcdb7d3b4b7586c7">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 54pt; vertical-align: top;">(a)</td>
          <td style="width: auto; vertical-align: top;">
            <div>the Company&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/ef20039018_10k.htm/000114036125004907/0001140361-25-004907-index.html">Annual Report on Form 10-K</a> for the year ended December 31, 2024;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z202d539eb08c43e3bf8069240bcc72a2">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 54pt; vertical-align: top;">(b)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company&#8217;s <a href="https://www.sec.gov/Archives/edgar/data/1021561/000114036125018024/0001140361-25-018024-index.htm">Quarterly Report on Form 10-Q</a> for the quarter ended March 31, 2025;</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zd03934c4ce614221884030810e18eabf">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 54pt; vertical-align: top;">(c)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the Company&#8217;s Current Reports on Form 8-K filed on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1021561/000114036125000113/ef20041017_8k.htm">January 3, 2025</a>, <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1021561/000114036125007278/ef20044848_8k.htm">March 6, 2025</a>, and <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1021561/000114036125020939/ef20049959_8k.htm">May 30, 2025</a>;
              and</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z7594cef1a5b14a4c819ffb9f9043f5ab">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 54pt; vertical-align: top;">(d)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>the description of the Company&#8217;s Class A Common Stock filed as <a href="https://www.sec.gov/Archives/edgar/data/1021561/000114036124008111/ef20015265_ex4-2.htm">Exhibit 4.2</a> to the Company&#8217;s Annual Report on Form 10-K for the fiscal
              year ended December 31, 2023, filed on February 15, 2024, together with any amendment or report filed with the Commission for the purpose of updating such description.</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="text-align: justify;">All documents filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), subsequent to the date hereof and prior to the filing of a
      post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities remaining unsold shall be deemed to be incorporated by reference herein and to be a part hereof from the respective dates
      of filing of such documents.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a
      statement contained herein or in any other subsequently filed document that also is, or is deemed to be, incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so
      modified or superseded, to constitute a part of this Registration Statement.</div>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z3b4a2575e7d44b588d83209d4bbad428" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 36pt;">
              <div style="text-align: left;"><font style="font-weight: bold;">Item 8.</font></div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto;">
              <div><font style="font-weight: bold;">Exhibits.</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div>&#160;</div>
    <div style="text-align: justify;">Unless otherwise noted, the SEC file number for exhibits incorporated by reference is 001-12421.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z9ba75246137849fa8e5e0eb6c2235cd0">

        <tr>
          <td style="width: 9.69%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Exhibit Number</div>
          </td>
          <td style="width: 90.31%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Description of Document</div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">4.1</div>
          </td>
          <td style="width: 90.31%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 255);"><a href="https://www.sec.gov/Archives/edgar/data/1021561/0000950109-96-005995.txt">Amended and Restated Certificate of Incorporation of the Company (incorporated by reference to Exhibit 3.1 to the Company&#8217;s
                Registration Statement on Form S-1 filed September 16, 1996, File No. 333-12073).</a></div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 9.69%; vertical-align: top;" rowspan="1">&#160;</td>
          <td style="width: 90.31%; vertical-align: top;" rowspan="1">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">4.2</div>
          </td>
          <td style="width: 90.31%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 255);"><a href="https://www.sec.gov/Archives/edgar/data/1021561/000102156110000024/ex3-2.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit
                3.2 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2009, filed March 1, 2010).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top;">&#160;</td>
          <td style="width: 90.31%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">4.3</div>
          </td>
          <td style="width: 90.31%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 255);"><a href="https://www.sec.gov/Archives/edgar/data/1021561/000103393205000011/ex3-3.htm">Certificate of Designation, Preferences and Relative Participating, Optional and Other Special Rights of Preferred Stock
                and Qualifications, Limitations and Restrictions Thereof (incorporated by reference to Exhibit 3.3 to the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2004, filed March 15, 2005).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top;">&#160;</td>
          <td style="width: 90.31%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">4.4</div>
          </td>
          <td style="width: 90.31%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 255);"><a href="https://www.sec.gov/Archives/edgar/data/1021561/000114036124045001/ef20037801_ex3-1.htm">Sixth Amended and Restated Bylaws of Nu Skin Enterprises, Inc. (incorporated by reference to Exhibit 3.1 to
                the Company&#8217;s Current Report on Form 8-K filed November 1, 2024).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top;">&#160;</td>
          <td style="width: 90.31%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">4.5</div>
          </td>
          <td style="width: 90.31%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 255);"><a href="https://www.sec.gov/Archives/edgar/data/1021561/000114036123007348/brhc10046901_ex4-1.htm">Specimen Form of Stock Certificate for Class A Common Stock (incorporated by reference to Exhibit 4.1 to the
                Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2022, filed February 16, 2023).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top;">&#160;</td>
          <td style="width: 90.31%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">5.1*</div>
          </td>
          <td style="width: 90.31%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);"><a href="ef20049856_ex5-1.htm">Opinion of Barnes &amp; Thornburg LLP.</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top;">&#160;</td>
          <td style="width: 90.31%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">23.1*</div>
          </td>
          <td style="width: 90.31%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);"><a href="ef20049856_ex5-1.htm">Consent of Barnes &amp; Thornburg LLP (included as part of Exhibit 5.1).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top;">&#160;</td>
          <td style="width: 90.31%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">23.2*</div>
          </td>
          <td style="width: 90.31%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);"><a href="ef20049856_23-2.htm">Consent of PricewaterhouseCoopers LLP, independent registered public accounting firm.</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top;">&#160;</td>
          <td style="width: 90.31%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">24.1*</div>
          </td>
          <td style="width: 90.31%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);"><a href="#POWEROFATTORNEY">Power of Attorney (included in the signature pages to this Registration Statement).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top;">&#160;</td>
          <td style="width: 90.31%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">99.1</div>
          </td>
          <td style="width: 90.31%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div><a href="https://www.sec.gov/Archives/edgar/data/1021561/000114036125020939/ef20049959_ex10-1.htm">Nu Skin Enterprises, Inc. Amended and Restated 2024 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 to the Company&#8217;s
                Current Report on Form 8-K filed May 30, 2025).</a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top;">&#160;</td>
          <td style="width: 90.31%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 9.69%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="text-align: center; color: rgb(0, 0, 0);">107.1*</div>
          </td>
          <td style="width: 90.31%; vertical-align: top; background-color: rgb(204, 238, 255);">
            <div style="color: rgb(0, 0, 0);"><a href="ef20049856_ex107-1.htm">Filing Fee Table.</a></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="left" style="height: 2px; width: 15%; color: #000000; background-color: #000000; margin-left: 0px; margin-right: auto; border: none;"></div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z78972759281a4a8e8ade50bad96271f6">

        <tr>
          <td style="width: 9pt; vertical-align: top;">*</td>
          <td style="width: auto; vertical-align: top;">
            <div>Filed herewith</div>
          </td>
        </tr>

    </table>
    <div>&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-weight: bold;"><a name="Section4"></a>SIGNATURES</div>
    <div>&#160;</div>
    <div style="text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S&#8209;8 and has duly caused this
      registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Provo, State of Utah, on this 2nd day of June, 2025.</div>
    <div>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z3b75d1a6516b48388dad1632a19cb834">

        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td colspan="2" style="vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">NU SKIN ENTERPRISES, INC.</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: bottom;">&#160;</td>
          <td style="width: 5%; vertical-align: bottom;">&#160;</td>
          <td style="width: 45%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">By:</div>
          </td>
          <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>/s/ <font style="color: rgb(0, 0, 0);">Ryan S. Napierski</font></div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Name:</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Ryan S. Napierski</div>
          </td>
        </tr>
        <tr>
          <td colspan="1" style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 5%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Title:</div>
          </td>
          <td style="width: 45%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">President and Chief Executive Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: center; font-weight: bold;"><a name="POWEROFATTORNEY"><!--Anchor--></a>POWER OF ATTORNEY</div>
    <div style="text-align: center; font-weight: bold;"> <br>
    </div>
    <div style="text-align: justify;">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Ryan S. Napierski, Chayce D. Clark and Gregory S. Belliston, and each of them, any of whom may act
      without joinder of the other, the individual&#8217;s true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for the person and in his or her name, place and stead, in any and all capacities, to sign any and all
      amendments (including post-effective amendments) to this Registration Statement, and to file the same, with all exhibits thereto and all documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each
      of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and
      confirming all that said attorneys-in-fact and agents or any of them, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. This power of attorney shall be governed by and construed with the laws of the State
      of Delaware and applicable federal securities laws.</div>
    <div>&#160;</div>
    <div style="text-align: justify;">Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities indicated on the 2nd day of June, 2025.</div>
    <br>
    <table cellspacing="0" cellpadding="0" border="0" style="border-collapse: collapse; width: 70%; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;" id="z5e67b25133a345caa8166a9511219a66">

        <tr>
          <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-right: 2.25pt; margin-left: 2.25pt; font-weight: bold;">Signature</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-right: 2.25pt; margin-left: 6.75pt; font-weight: bold;">Title</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">/s/ <font style="color: rgb(0, 0, 0);">Steven J. Lund</font></div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td rowspan="2" style="width: 40%; vertical-align: middle;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Executive Chairman of the Board</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: top;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt; color: rgb(0, 0, 0);">Steven J. Lund</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">/s/ Ryan S. Napierski</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td rowspan="2" style="width: 40%; vertical-align: middle;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">President, Chief Executive Officer and Director</div>
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">(Principal Executive Officer)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: top;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Ryan S. Napierski</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">/s/ James D. Thomas</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td rowspan="2" style="width: 40%; vertical-align: middle;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Chief Financial Officer</div>
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">(Principal Financial Officer and Accounting Officer)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: top;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">James D. Thomas</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">/s/ Emma S. Battle</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td rowspan="2" style="width: 40%; vertical-align: middle;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Director</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: top;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Emma S. Battle</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">/s/ Daniel W. Campbell</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td rowspan="2" style="width: 40%; vertical-align: middle;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Director</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: top;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Daniel W. Campbell</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="margin-right: 2.25pt;">/s/ Laura Nathanson</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td rowspan="2" style="width: 40%; vertical-align: middle;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Director</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: top;">
            <div style="margin-right: 2.25pt;">Laura Nathanson</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">/s/ Thomas R. Pisano</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td rowspan="2" style="width: 40%; vertical-align: middle;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Director</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: top;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Thomas R. Pisano</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">/s/ James M. Winett</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td rowspan="2" style="width: 40%; vertical-align: middle;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Director</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: top;">
            <div style="margin-right: 2.15pt; margin-left: 2.15pt;">James M. Winett</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">/s/ Edwina D. Woodbury</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td rowspan="2" style="width: 40%; vertical-align: middle;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Director</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: top;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Edwina D. Woodbury</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td style="width: 40%; vertical-align: bottom;"><br>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">/s/ Mark A. Zorko</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
          <td rowspan="2" style="width: 40%; vertical-align: middle;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Director</div>
          </td>
        </tr>
        <tr>
          <td style="width: 27%; vertical-align: top;">
            <div style="margin-right: 2.25pt; margin-left: 2.25pt;">Mark A. Zorko</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;"><br>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ef20049856_ex5-1.htm
<DESCRIPTION>OPINION OF BARNES & THORNBURG LLP
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div>
        <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 5.1</font><br>
        </div>
        <div>
          <div> <br>
          </div>
          <div>
            <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); width: 100%;">

                <tr>
                  <td style="width: 70%; text-align: left; vertical-align: top;"><img src="image00004.jpg"></td>
                  <td style="width: 30%; text-align: left; vertical-align: bottom;">
                    <div> <br>
                    </div>
                    <div> <br>
                    </div>
                    <br>
                  </td>
                </tr>
                <tr>
                  <td rowspan="1" style="width: 70%; text-align: left; vertical-align: top;"><br>
                  </td>
                  <td rowspan="1" style="width: 30%; text-align: left; vertical-align: bottom;">
                    <div> 1600 West End Avenue<br>
                      Suite 800<br>
                      Nashville, TN 37203-3494 U.S.A<br>
                      (615) 621-6021<br>
                    </div>
                    <div> <br>
                    </div>
                    <div>www.btlaw.com</div>
                  </td>
                </tr>

            </table>
          </div>
        </div>
      </div>
      <div>&#160;</div>
      <div style="text-align: justify;"><a name="bmkDate"></a>June 2, 2025</div>
      <div>&#160;</div>
      <div style="color: #000000;"><a name="bmkName"></a>Nu Skin Enterprises, Inc.</div>
      <div style="color: #000000;">75 West Center Street</div>
      <div style="color: #000000;">Provo, Utah 84601</div>
      <div><br>
      </div>
      <div style="text-align: justify; color: #000000;">Re: Registration Statement on Form S-8</div>
      <div><br>
      </div>
      <div style="text-align: justify;"><font style="color: #000000;">Ladies and Gentlemen</font>:</div>
      <div>&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We have acted as counsel to Nu Skin Enterprises, Inc., a Delaware corporation (the &#8220;<font style="font-weight: bold; font-style: italic;">Company</font>&#8221;), in connection with the
        preparation and filing of a Registration Statement on Form S-8 (the &#8220;<font style="font-weight: bold; font-style: italic;">Registration Statement</font>&#8221;) relating to an additional 790,000 shares (the &#8220;<font style="font-weight: bold; font-style: italic;">Shares</font>&#8221;) of the Company&#8217;s Class A Common Stock, par value $0.001 per share (the &#8220;<font style="font-weight: bold; font-style: italic;">Common Stock</font>&#8221;) that may be issued pursuant to the Company&#8217;s Amended and Restated 2024
        Omnibus Incentive Plan (the &#8220;<font style="font-weight: bold; font-style: italic;">Plan</font>&#8221;).</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">In connection with this opinion, we have examined and relied upon such records, documents, certificates, and other instruments as we have deemed necessary or appropriate in order to
        express the opinions hereinafter set forth. We have also assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of
        all documents submitted to us as copies, the authenticity of the originals of such latter documents, the legal competence of all signatories to such documents, and, except to the extent we express an opinion as to due authorization in the next
        paragraph of this letter, the due authorization, execution and delivery of all documents by the parties thereto. As to various questions of fact relevant to the opinion expressed herein, we have relied upon, and assume the accuracy of, certificates
        and oral or written statements and other information of or from public officials and officers and representatives of the Company.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">For purposes of the opinion set forth below, we have assumed that no event occurs that causes the number of authorized shares of Common Stock available for issuance by the Company
        to be less than the number of then unissued Shares.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">Based upon and subject to the qualifications, assumptions and limitations set forth herein, we are of the opinion that the Shares have been duly authorized and, when issued and
        delivery against payment therefor in accordance with the terms of the Plan, will be validly issued, fully paid and non-assessable.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">The opinions expressed above are limited to the General Corporation Law of the State of Delaware (which includes applicable provisions of the Delaware Constitution and reported
        judicial decisions interpreting the General Corporation Law of the State of Delaware and the Delaware Constitution).</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">We hereby consent to the filing of this opinion with the Securities and Exchange Commission (the &#8220;<font style="font-weight: bold; font-style: italic;">Commission</font>&#8221;) as Exhibit
        5.1 to the Registration Statement. In giving this consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended, or the rules and regulations of the
        Commission.</div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;"> <br>
      </div>
      <div style="text-align: center;"><img src="image00005.jpg"></div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">
        <div style="text-indent: 0px;">June 2, 2025</div>
        <div style="text-indent: 0px;"><a name="bmkPageNo"></a>Page 2</div>
        <div style="text-indent: 0px;"><font class="BRPFPageNumber"> <br>
          </font></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">This opinion is limited to the specific issues addressed herein, and no opinion may be inferred or implied beyond that expressly stated herein.</div>
      <div><br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">This opinion is furnished to you in connection with the filing of the Registration Statement. Our opinion is rendered as of the date hereof, and we assume no obligation to advise
        you of changes in law or fact (or the effect thereof on the opinions expressed herein) that hereafter may come to our attention.</div>
      <div style="text-align: justify; color: rgb(0, 0, 0);"> <br>
      </div>
      <div style="text-align: justify; text-indent: 36pt; color: #000000;">
        <table cellspacing="0" cellpadding="0" border="0" id="zc975e54a50b64049b7451e9fde3e6bc5" style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; width: 100%;">

            <tr>
              <td style="width: 60%;"><br>
              </td>
              <td style="width: 40%;">Very truly yours,</td>
            </tr>
            <tr>
              <td rowspan="1" style="width: 60%;"><br>
              </td>
              <td rowspan="1" style="width: 40%;"><br>
              </td>
            </tr>
            <tr>
              <td style="width: 60%;"><br>
              </td>
              <td style="width: 40%;">/s/ Barnes &amp; Thornburg LLP</td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div><img src="image00001.jpg">
        <div><br>
          <br>
        </div>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); text-align: center; border: medium none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.2
<SEQUENCE>3
<FILENAME>ef20049856_23-2.htm
<DESCRIPTION>CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div style="text-align: right; color: #000000; font-weight: bold;">Exhibit 23.2</div>
      <div>&#160;</div>
      <div style="text-align: center; color: #000000;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</div>
      <div>&#160;</div>
      <div style="color: #000000;">We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Nu Skin Enterprises, Inc. of our report dated February
        14, 2025 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in Nu Skin Enterprises, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2024.</div>
      <div>&#160;</div>
      <div style="color: #000000;">/s/ PricewaterhouseCoopers LLP</div>
      <div style="color: #000000;">Salt Lake City, Utah</div>
      <div style="color: #000000;">June 2, 2025</div>
      <div><br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
      <div><br>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ef20049856_ex107-1.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.5.1.5318
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  <div>
    <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 107.1</font><br>
    </div>
    <div><br>
    </div>
    <div>
      <div style="text-align: center; font-weight: bold;"><a name="z_Hlk165644743"></a>Calculation of Filing Fee Tables</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Form S-8</div>
      <div style="text-align: center;">(Form Type)</div>
      <div>&#160;</div>
      <div style="text-align: center; font-weight: bold;">Nu Skin Enterprises, Inc.</div>
      <div style="text-align: center;">(Exact Name of Registrant as Specified in its Charter)</div>
      <div>&#160;</div>
      <div style="text-align: center;">Table 1 &#8211; Newly Registered Securities</div>
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="2" border="0" class="cfttable" id="z8fd9a1645f7749408da22a11c949b5fc" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;">

          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Security Type</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 16%; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Security Class Title</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-weight: bold;">Fee</div>
              <div style="text-align: center; color: #000000; font-weight: bold;">Calculation</div>
              <div style="text-align: center; color: #000000; font-weight: bold;">Rule</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-weight: bold;">Amount</div>
              <div style="text-align: center; color: #000000; font-weight: bold;">Registered<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-weight: bold;">Proposed</div>
              <div style="text-align: center; color: #000000; font-weight: bold;">Maximum</div>
              <div style="text-align: center; color: #000000; font-weight: bold;">Offering</div>
              <div style="text-align: center; color: #000000; font-weight: bold;">Price Per</div>
              <div style="text-align: center; color: #000000; font-weight: bold;">Unit<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-weight: bold;">Maximum</div>
              <div style="text-align: center; color: #000000; font-weight: bold;">Aggregate</div>
              <div style="text-align: center; color: #000000; font-weight: bold;">Offering Price<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Fee Rate</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 12%; border-color: rgb(0, 0, 0); border-style: solid; border-width: 2px;">
              <div style="text-align: center; color: #000000; font-weight: bold;">Amount of</div>
              <div style="text-align: center; color: #000000; font-weight: bold;">Registration Fee</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: middle; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Equity</div>
            </td>
            <td valign="bottom" style="vertical-align: middle; width: 16%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Class A Common Stock, par value $0.001 per share</div>
            </td>
            <td valign="bottom" style="vertical-align: middle; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: rgb(0, 0, 0);">Other</div>
            </td>
            <td nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">790,000</div>
            </td>
            <td nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div>$7.21</div>
            </td>
            <td class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div>$5,695,900.00</div>
            </td>
            <td class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">0.0001531</div>
            </td>
            <td class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div>$872.04</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" colspan="4" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">Total Offering Amounts</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div>$5,695,900.00</div>
            </td>
            <td class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div>$872.04</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" colspan="4" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">Total Fee Offsets</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">$ &#8212;</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" colspan="4" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div style="color: rgb(0, 0, 0);">Net Fee Due</div>
            </td>
            <td valign="bottom" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td class="cftnumcell" colspan="1" style="vertical-align: middle; text-align: center; width: 12%; border-bottom: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-left: 2px solid rgb(0, 0, 0);">
              <div>$872.04</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z4d2c93782bb74bfcbe5cea3ecf141dd2">

          <tr>
            <td style="width: 18pt; vertical-align: top;">(1)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Pursuant to Rule 416(a) under the Securities Act of 1933 (the &#8220;Securities Act&#8221;), this Registration Statement on Form S-8 also relates to such additional number of shares of the Company&#8217;s Class A Common Stock available for issuance under
                the Company&#8217;s Amended and Restated 2024 Omnibus Incentive Plan (the &#8220;Plan&#8221;) as may be required pursuant to the plan in the event of a stock dividend, stock split, recapitalization or other similar event or transaction, or as otherwise
                provided for in the Plan.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z36a51b0488d14277bb1cefb49503572b">

          <tr>
            <td style="width: 18pt; vertical-align: top;">(2)</td>
            <td style="width: auto; vertical-align: top;">
              <div>Estimated solely for the purpose of calculating the registration fee in accordance with Rule 457(c)&#160;and (h)&#160;under the Securities Act, on the basis of the average of the high and low prices per share of the Company&#8217;s Class A Common Stock
                as reported on the New York Stock Exchange on May 23, 2025.</div>
            </td>
          </tr>

      </table>
      <div>&#160;</div>
      <div> <br>
      </div>
    </div>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  C +4# 2(  A$! Q$!_\0
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M82P&150N7!90-N <'- '=4444 %<MJT;RZ7>QQJ6=X755'<E3@5U-9'V*?\
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M"A&"J;V.T8)''8T =I1110 4444 %%%% !1110 4444 %%%% !1110 4444
7%%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00004.jpg
<TEXT>
begin 644 image00004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  O &H# 2(  A$! Q$!_\0
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MX_*I=)^-U[;?\)-9:O!I>J7NE6!O[>YTB8R07('\)_ND=3[ T >]4C,%4LQ
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>>@_"3P7H6JPZC8:-&+J [H&D=G$)]5!.!7>4 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image00005.jpg
<TEXT>
begin 644 image00005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  B F0# 2(  A$! Q$!_\0
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M#L=+ADD6"T:W,;.=[$0NC $]\[ "?>GZUHUMK$6RZ:9?W;QJT3[63=CY@>S
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MH"6?B/4=6.T/<QQP(B$X54&"YS_&P" ^T2>E &[1110 4444 %%%% !1110
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MA+>2(WDMY I,H)4,2N$)(P Q&3C%3Z=X7L;$715[B62ZA:&>21P6DW.[LQP
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
.**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
